NEW YORK ( TheStreet) -- POZEN (Nasdaq: POZN) hit a new 52-week high Thursday as it is currently trading at $7.98, above its previous 52-week high of $7.95 with 205,919 shares traded as of 10:19 a.m. ET. Average volume has been 436,500 shares over the past 30 days. POZEN has a market cap of $231.1 million and is part of the health care sector and drugs industry. Shares are up 100.3% year to date as of the close of trading on Wednesday. POZEN Inc., a pharmaceutical company, develops products for the treatment of acute and chronic pain, and other pain-related conditions in the United States. The company has a P/E ratio of 5.5, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates POZEN as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full POZEN Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.